Design, synthesis and biological evaluation of a novel class of anticancer agents: anthracenylisoxazole lexitropsin conjugates.
Han X, Li C, Mosher MD, Rider KC, Zhou P, Crawford RL, Fusco W, Paszczynski A, Natale NR. Bioorg Med Chem. 2009 Feb 15; 17(4):1671-80. Epub 2008 Dec 31.